Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioLase Technology, Inc. (BLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Karl Drobnic who wrote (518)	3/8/1999 8:48:00 AM
From: Archie Goodwin	Read Replies (2) \| Respond to of 706

SAN CLEMENTE, Calif., March 8 /PRNewswire/ -- BIOLASE TECHNOLOGY, INC. (Nasdaq: BLTI) announced it just received clearance from the Food and Drug Administration (FDA) that allows the Millennium Hydrokinetic Er, Cr: YSGG (TM) laser to be marketed for all classes of cavity preparations. The Millennium can now provide the benefits of drill-free dentistry for millions of patients. Hydrokinetic YSGG technology combines laser energy and water to painlessly cut enamel, dentin and caries in the majority of cases. The new clearance for Class II and IV preparations combined with the previous clearances for Classes I, III and V completes Biolase's clearance for all dental caries classifications. The indications for use now include all classes of cavity preparations, I-V, caries removal and hard tissue surface roughening or etching. In addition to the hard tissue clearances, the Hydrokinetic YSGG technology was previously cleared for soft tissue surgical procedures. Er, Cr: YSGG (erbium, chromium, yttrium, scandium, gallium and garnet) produces a superior wavelength of 2,780 nanometers with numerous benefits including: faster results cutting enamel, dentin and caries; higher quality fiber optic transmission with excellent reliability; effectively cuts and coagulates soft tissue; avoids many common problems of the high speed drill including micro fissures which weaken the tooth structure; does not leave a layer of smear which creates a better surface for bonding; and most procedures can be done without anesthesia, without needles or patient trauma. Jeffrey W. Jones, Biolase President and CEO, stated "Our goal at Biolase is to provide painless dentistry for people around the world. Obtaining clearances for all classes of preps is a significant step towards this goal. We believe that our Hydrokinetic YSGG technology will raise the standard of care for dentists and their patients. This is a major step in introducing revolutionary technology that will change dentistry forever." BIOLASE Technology, Inc. (www.biolase.com) manufactures and markets advanced dental, cosmetic, aesthetic, and surgical products, including the LazerSmile tooth whitening system (www.lazersmile.com), Hydrokinetic(TM) surgical cutting systems, and other advanced laser and non-laser based products for the professional and home consumer market. The company's products incorporate patented and patent-pending technologies in the pursuit of painless surgery. The matters discussed in this news release include forward-looking statements which are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to, the effect of actions of third parties, including governmental officials, the timely development and acceptance of new products, the impact of competitive products and pricing, and other risks detailed from time-to-time in the Company's filings with the Securities and Exchange Commission, including the reports on Forms 10-K and 10-Q. These forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims, however, any intent or obligation to update these forward-looking statements. SOURCE BIOLASE Technology, Inc. -0- 03/08/99 /CONTACT: Scott Liolios of Pacific Consulting Group, Inc., 949-574-3860; or Jeffrey W. Jones of BIOLASE Technology, Inc., 949-361-1200/ /Web site: lazersmile.com /Web site: biolase.com (BLTI) CO: BIOLASE Technology, Inc. ST: California IN: MTC SU: * end of story * Regards A.G.